Scenario — Stimulant overdose at music festival
intermediate Toxicology · Adult · 35yr · female
Patient Information
| Dispatch | You are called to a patient (Mia Carlson, 35-year-old female) who has been brought to the FAP by friends at the Southbound Music Festival. Friends state she has taken 'something' and is behaving erratically and is very agitated. |
| Patient | Mia Carlson — 35yr (65kg) |
| Incident History | Pt's friends state she took an unknown pill approximately 90 minutes ago at the festival. She has become increasingly agitated, confused, and is sweating heavily. Friends deny any alcohol intake. |
| Emergency Contact | Tara Carlson (Sister) — 0412 874 331 |
Initial Rapid Assessment
| Response | Alert |
| Airway | Patent. Nil airway obstruction. Nil stridor. Patient able to vocalise. |
| Breathing | Rapid and shallow. Increased work of breathing noted. No audible wheeze or crackles. |
| Circulation | Pulse rapid and strong. Skin flushed and diaphoretic. No external haemorrhage identified. |
| Disability | GCS 13 (E3V4M6). Not orientated to time or place. Agitated and combative. Pupils dilated bilaterally. |
| Exposure | Diaphoresis noted across trunk and face. No visible wounds or rashes. Temperature elevated to touch. |
Vitals
| Time | SpO2 | Resp Dist | RR | Pulse | BP | CRT | GCS | PERL | Temp | BGL | Pain |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Initial | 97% (RA) | Mild | 24 | 132 | 158/100 | <2s | 13 | 6 6 SL | 38.8 | 5.4 mmol/L | 3 |
| 10 mins | 95% (O2 NRB 15L) | Moderate | 28 | 148 | 162/104 | <2s | 11 | 6 6 SL | 39.4 | 5.2 mmol/L | 5 |
History Taking
| Signs/Symptoms | Agitation, confusion, sweating heavily, headache, palpitations. Friends note she has been grinding her teeth. |
| Allergies | NKDA. |
| Medications | Oral contraceptive pill. No other regular medications. |
| Pertinent History | No known cardiac or psychiatric history. Occasional recreational drug use at festivals per friends. |
| Last Oral Intake | Ate a meal approximately 3 hours ago. Limited fluid intake during the day. No alcohol. |
| Events Leading | Patient was dancing at the main stage when friends noticed she became increasingly agitated and confused approximately 90 minutes after taking an unknown pill. |
| Treatment Prior | Nil treatment prior to EHS arrival. Friends encouraged her to sit down and brought her to the FAP. |
| Onset | Approximately 90 minutes ago following ingestion of an unknown pill described as 'white and small'. |
| Pain | Complaining of headache rated 5/10. Diffuse chest tightness 3/10. |
| Quality | Headache described as throbbing. Chest tightness diffuse and non-radiating. |
| Radiates | Nil radiation of chest discomfort. |
| Severity | Headache 5/10. Chest tightness 3/10. |
Scenario Progression and Treatment Objectives
Diagnosis
This patient is suffering from sympathomimetic toxicity consistent with stimulant (MDMA/methamphetamine-type) overdose, presenting with tachycardia, hypertension, hyperthermia, dilated pupils, agitation, diaphoresis, and deteriorating GCS.
Facilitator Triggers — if trainees miss a critical step
- ! (If scene safety and personal safety are not considered first — patient becomes more combative and attempts to leave the FAP. Prompt trainee: 'What is your priority before approaching this patient?')
- ! (If temperature is not assessed within the first 5 minutes — patient begins to shiver then becomes more confused. Facilitator states: 'The patient's skin now feels extremely hot to touch and she is less responsive.')
- ! (If BGL is not checked — facilitator prompts: 'What other assessment should you perform given her altered GCS?')
- ! (If the trainee attempts to administer any oral medication while GCS is 13 and patient is agitated — remind trainee that safe oral ingestion requires GCS 15/15 and patient cooperation.)
- ! (If cooling measures are not initiated within 5 minutes of temperature assessment — GCS drops to 11 and RR increases to 28 at the 10-minute vitals mark.)
- ! (If trainee attempts to administer a medication outside EHS scope such as a sedative or IV fluid — facilitator states: 'That medication/intervention is outside your scope. What can you do within your authorised scope?')
- ! (If an IMISTAMBO handover is not prepared as ambulance arrives — facilitator prompts: 'The ambulance crew is here. What information do you hand over?')
Treatment Objectives
- 1. Ensure personal safety and scene safety — approach only when patient is seated and not posing immediate danger to self or crew. Request Police assistance via State Operations Centre if patient becomes violently combative.
- 2. Perform Primary Survey — airway patent, breathing rapid but adequate, circulation intact with tachycardia, disability GCS 13 with dilated pupils, expose for diaphoresis and temperature assessment.
- 3. Apply pulse oximetry monitoring continuously.
- 4. Administer Oxygen via non-rebreather mask at 10–15 litres per minute — titrate to maintain SpO2 94–98%.
- 5. Perform full Vital Signs Survey including tympanic temperature — document tachycardia HR 132, hypertension BP 158/100, elevated temp 38.8°C, RR 24, GCS 13.
- 6. Perform blood glucose level (BGL) — result 5.4 mmol/L, no treatment required for hypoglycaemia.
- 7. Attempt to identify the agent involved — question friends for description of the pill, time of ingestion, dose, and any other substances taken. Place any packaging in patient medications bag if available.
- 8. Initiate active cooling measures — remove excess clothing, apply cool wet cloths to neck, groin and axilla, fan the patient. Do NOT immerse in ice bath at this temperature (38.8°C), but prepare for escalation if temperature rises.
- 9. Position patient in a position of comfort — seated or semi-recumbent. Do NOT restrain unless essential to prevent injury to patient or crew. Use minimum force necessary if restraint is required.
- 10. Use de-escalation techniques continuously — calm, quiet communication. Reassure patient and reduce stimulation in the environment.
- 11. Perform ongoing monitoring — repeat full observations every 5 minutes given potential for rapid deterioration. Document deteriorating GCS to 11 at 10 minutes.
- 12. Contact State Operations Centre / Clinical Support Paramedic early — advise of suspected stimulant toxicity, deteriorating GCS, hyperthermia, and request Priority 1 ambulance with pre-notification to receiving ED.
- 13. Do NOT administer any oral medication — patient GCS and agitation preclude safe oral administration. Methoxyflurane is contraindicated as patient is unable to cooperate and has altered conscious state.
- 14. Do NOT induce vomiting.
- 15. Collect all medication packaging and personal effects — place in green and white patient medications bag.
- 16. Prepare IMISTAMBO handover for ambulance crew — include: suspected sympathomimetic toxicity, unknown pill ~90 min ago, HR 148, BP 162/104, temp 39.4°C, GCS 11, cooling initiated, no medications administered by EHS.
- 17. Scenario ends on arrival of ambulance and IMISTAMBO handover.
- 18. Attention to hand hygiene will be given throughout the scenario.
Clinical references: Poisons & Overdoses · Disturbed & Abnormal Behaviour · Heat Stroke · Unconsciousness · Primary Survey
How did you go? Next scenario →
Report a clinical error
Describe what you believe is incorrect. This will be flagged for clinical review.